Ledger.Open graph →
SEC Form D · filed August 24, 2022

RevOpsis Therapeutics, Inc

Offering
$18.0M
Sold
$100K
Exemption
Rule 506(c)
Industry
Biotechnology
Location
Springfield, IL
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (9)

Ramanath Bhandari · Springfield, ILExec · Director · PromoterJeff P. Olson · Springfield, ILDirectorRam P. Palanki · Springfield, ILExec · DirectorSabrina Vallano · London, United KingdomExec · Director · PromoterSteven Decillis · NEW YORK, NYExec · DirectorAnne Labelle · Vancouver, British Columbia, CanadaDirectorCarly Brantz · SAN FRANCISCO, CAExec · Director · PromoterScott P. Lennon · Camana Bay, Grand Cayman, Cayman IslandsDirectorClaire P. Musgrave · Camana Bay, Grand Cayman, Cayman IslandsExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗